1,816
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Development and validation of a platform reduced intact mass method for process monitoring of monoclonal antibody glycosylation during routine manufacturing

, , &
Pages 1301-1312 | Received 03 Sep 2020, Accepted 23 Oct 2020, Published online: 17 Nov 2020

References

  • Ambrogelly A, Gozo S, Katiyar A, et al. Analytical comparability study of recombinant monoclonal antibody therapeutics. mAbs. 2018;10(4):513–538.
  • Zhang P, Woen S, Wang T, et al. Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs. Drug Discov Today. 2016;21(5):740–765.
  • Gomes RA, Almeida C, Correia C, et al. Exploring the analytical power of the QTOF MS platform to assess monoclonal antibodies quality attributes. Plos One. 2019;14(7):e0219156.
  • Liu P, Zhu X, Wu W, et al. Subunit mass analysis for monitoring multiple attributes of monoclonal antibodies. Rapid Commun Mass Spectrom. 2019;33(1):31–40.
  • Carillo S, Perez-Robles R, Jakes C, et al. Comparing different domains of analysis for the characterization of N-glycans on monoclonal antibodies. J Pharm Anal. 2020;10(1):23–34.
  • Redman EA, Batz NG, Mellors JS, et al. Integrated microfluidic capillary electrophoresis-electrospray ionization devices with online MS detection for the separation and characterization of intact monoclonal antibody variants. Anal Chem. 2015;87(4):2264–2272.
  • Wang Y, Feng P, Sosic Z, et al. Monitoring glycosylation profile and protein titer in cell culture samples using ZipChip CE-MS. J Anal Bioanal Tech. 2017;8(2). DOI:10.4172/2155-9872.1000359
  • Rogers RS, Nightlinger NS, Livingston B, et al. Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics. mAbs. 2015;7(5):881–890.
  • Rogstad S, Yan H, Wang X, et al. Multi-attribute method for quality control of therapeutic proteins. Anal Chem. 2019;91(22):14170–14177.
  • Sokolowska I, Mo J, Pirkolachahi FR, et al. Implementation of a high-resolution liquid chromatography−mass spectrometry method in quality control laboratories for release and stability testing of a commercial antibody product. Anal Chem. 2020;92(3):2369–2373.
  • Guidance for Industry. Part 11, electronic records; electronic signatures – scope and application. US Food and Drug Administration.
  • Goetze AM, Liu YD, Zhang Z, et al. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. Glycobiology. 2011;21(7):949–959.
  • DePalma A. Glycosylation: the key to quality. Genet Eng Biotech N. 2015 March 15;35(6).
  • Brantley TJ, Mitchelson FG, Khattak SF. A class of low-cost alternatives to kifunensine for increasing high mannose N-linked glycosylation for monoclonal antibody production in Chinese hamster ovary cells. Biotechnol Prog. 2020;XX–XX. DOI:10.1002/btpr.3076
  • Reusch D, Tejada ML. Fc glycans of therapeutic antibodies as critical quality attributes. Glycobiology. 2015;25(12):1325–1334.
  • Planinc A, Bones J, Dejaegher B, et al. Glycan characterization of biopharmaceuticals: updates and perspectives. Anal Chim Acta. 2016;921:13–27.